الشرى المزمن أثناء الحمل أو الرضاعة — عندما يكون النظام الأولي لمضاد الهيستامين غير كافٍ

References

DOI: 10.1111/all.70210

• We suggest using the same treatment algorithm with caution both in pregnant and lactating women after risk-benefit assessment.
• Drugs contraindicated or not suitable in pregnancy should not be used.
• The increased dosage of modern 2nd generation H1-antihistamines can only be carefully suggested in pregnancy since safety studies have not been done, and with loratadine it must be remembered that this drug is metabolized in the liver which is not the case for its metabolite desloratadine.
• The goal of treatment is to treat the disease until it is gone, as efficiently and as safely as possible, aiming at a continuous complete control (consistently UAS = 0/UCT = 16) and a normalization of quality of life.